UBS Group’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.38M Sell
397,133
-20,488
-5% -$226K ﹤0.01% 3173
2025
Q1
$3.73M Buy
417,621
+243,376
+140% +$2.17M ﹤0.01% 3195
2024
Q4
$1.64M Buy
174,245
+143,488
+467% +$1.35M ﹤0.01% 3879
2024
Q3
$248K Sell
30,757
-3,015
-9% -$24.3K ﹤0.01% 4542
2024
Q2
$286K Sell
33,772
-25,317
-43% -$215K ﹤0.01% 4311
2024
Q1
$530K Sell
59,089
-11,917
-17% -$107K ﹤0.01% 4065
2023
Q4
$798K Buy
71,006
+17,288
+32% +$194K ﹤0.01% 3599
2023
Q3
$464K Buy
53,718
+11,007
+26% +$95K ﹤0.01% 3658
2023
Q2
$442K Buy
42,711
+15,987
+60% +$165K ﹤0.01% 3919
2023
Q1
$290K Buy
26,724
+18,068
+209% +$196K ﹤0.01% 4090
2022
Q4
$97.1K Buy
8,656
+8,556
+8,556% +$96K ﹤0.01% 5009
2022
Q3
$1K Sell
100
-193
-66% -$1.93K ﹤0.01% 8930
2022
Q2
$2K Sell
293
-3,256
-92% -$22.2K ﹤0.01% 8571
2022
Q1
$34K Buy
3,549
+1,101
+45% +$10.5K ﹤0.01% 5850
2021
Q4
$27K Buy
2,448
+1,683
+220% +$18.6K ﹤0.01% 6392
2021
Q3
$6K Buy
765
+665
+665% +$5.22K ﹤0.01% 7297
2021
Q2
$1K Sell
100
-218,938
-100% -$2.19M ﹤0.01% 8077
2021
Q1
$4.47M Buy
219,038
+50,839
+30% +$1.04M ﹤0.01% 2067
2020
Q4
$2.99M Buy
168,199
+85,425
+103% +$1.52M ﹤0.01% 2279
2020
Q3
$1.22M Buy
82,774
+80,249
+3,178% +$1.19M ﹤0.01% 2796
2020
Q2
$53K Sell
2,525
-1,953
-44% -$41K ﹤0.01% 4972
2020
Q1
$104K Buy
4,478
+1,953
+77% +$45.4K ﹤0.01% 4404
2019
Q4
$65K Sell
2,525
-197,577
-99% -$5.09M ﹤0.01% 5171
2019
Q3
$3.9M Buy
200,102
+192,545
+2,548% +$3.75M ﹤0.01% 2046
2019
Q2
$123K Buy
7,557
+2,611
+53% +$42.5K ﹤0.01% 4413
2019
Q1
$112K Sell
4,946
-24,546
-83% -$556K ﹤0.01% 4207
2018
Q4
$754K Buy
29,492
+23,324
+378% +$596K ﹤0.01% 3202
2018
Q3
$201K Buy
6,168
+3,083
+100% +$100K ﹤0.01% 4230
2018
Q2
$70K Sell
3,085
-1,426
-32% -$32.4K ﹤0.01% 4839
2018
Q1
$109K Buy
4,511
+2,117
+88% +$51.2K ﹤0.01% 4341
2017
Q4
$67K Sell
2,394
-4,825
-67% -$135K ﹤0.01% 4683
2017
Q3
$247K Buy
7,219
+4,794
+198% +$164K ﹤0.01% 3881
2017
Q2
$96K Buy
2,425
+2,225
+1,113% +$88.1K ﹤0.01% 4312
2017
Q1
$7K Hold
200
﹤0.01% 5903
2016
Q4
$6K Sell
200
-3,083
-94% -$92.5K ﹤0.01% 6192
2016
Q3
$119K Buy
3,283
+2,319
+241% +$84.1K ﹤0.01% 4065
2016
Q2
$21K Sell
964
-451
-32% -$9.83K ﹤0.01% 5393
2016
Q1
$26K Sell
1,415
-4,146
-75% -$76.2K ﹤0.01% 5193
2015
Q4
$91K Buy
5,561
+5,061
+1,012% +$82.8K ﹤0.01% 4298
2015
Q3
$6K Sell
500
-374
-43% -$4.49K ﹤0.01% 6203
2015
Q2
$12K Hold
874
﹤0.01% 5865
2015
Q1
$15K Sell
874
-1,931
-69% -$33.1K ﹤0.01% 5612
2014
Q4
$42K Buy
+2,805
New +$42K ﹤0.01% 4872